Strong box office momentum from Christopher Nolan’s *The Odyssey*, which drove IMAX’s global screen share to record levels and prompted multiple upward revisions to Q3 2026 revenue and adjusted EBITDA estimates, underpins the 81.5% implied probability that IMAX will beat quarterly earnings. The company has beaten consensus EPS and revenue in its prior two quarters, with Q2 2026 EPS surprising by over 50%, while recent analyst actions—including Wedbush and Wells Fargo price-target increases—reflect expectations for revenue near $150–164 million and EPS growth exceeding 75% year-over-year. A Moderate Buy consensus rating and history of outperformance in 79% of recent quarters further support trader positioning ahead of the upcoming release.